1149. Baseline Chest CT Findings in Patients with Pulmonary Mold Infections: A Post-Hoc Analysis from the Phase 3 SECURE Study that Compared Isavuconazole to Voriconazole for the Primary Treatment of Invasive Mold Disease

BACKGROUND: SECURE was a global, double-blind, Phase 3 study that randomized 527 patients 1:1 to isavuconazole (ISAV) or voriconazole (VORI) for the primary treatment of invasive mold disease (IMD) caused by Aspergillus or other filamentous fungi. Patients were classified as having proven/probable I...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Kamal, Engelhardt, Marc, Saulay, Mikael, Kovanda, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777367/
http://dx.doi.org/10.1093/ofid/ofaa439.1335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777367/
http://dx.doi.org/10.1093/ofid/ofaa439.1335

Ejemplares similares